Skip to main content

Peri-implant Bone and Soft Tissues

0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Geistlich Pharma
Geistlich PharmaSwitzerland - Root
1 program
Sandwich bone augmentationN/A1 trial
Active Trials
NCT07832565Not Yet Recruiting30Est. Dec 2028

Trial Timeline

Clinical trial activity over time

2026
2027
2028
Geistlich PharmaSandwich bone augmentation

Clinical Trials (1)

Total enrollment: 30 patients across 1 trials

NCT07832565Geistlich PharmaSandwich bone augmentation

Sandwich vs. Mixed Bone Augmentation for Implant Placement

Start: Nov 2026Est. completion: Dec 202830 patients
N/ANot Yet Recruiting

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

1 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.